DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02067910 (ClinicalTrials.gov)	August 2014	14/2/2014	Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome	Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAP III Study = Abatacept Sjögren Active Patients Phase III Study)	Sjögren's Syndrome	Drug: Abatacept SC	University Medical Center Groningen	Bristol-Myers Squibb	Completed	18 Years	N/A	All	80	Phase 3	Netherlands

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02067910
(ClinicalTrials.gov)

August 2014

14/2/2014

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome

Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome (ASAP III Study = Abatacept Sjögren Active Patients Phase III Study)

Sjögren's Syndrome

Drug: Abatacept SC

University Medical Center Groningen

Bristol-Myers Squibb

Completed

18 Years

N/A

All

Phase 3

Netherlands